The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

Life Sciences Corp. (NASDAQ:ATNF), a pharmaceutical preparations company with a market capitalization of $2.79 million, has amended the separation agreement with its former CEO, James N. Woody, ...

The three-building Muse campus is a few miles from Breakthrough’s Torrey Heights campus, which opened in September.

Bleakley Financial Group LLC lowered its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% during the 4th ...

Life science real estate developer Breakthrough Properties bought the three-building Muse complex at 3030, 3040 and 3050 ...

Lake Street analyst Thomas Flaten reiterated a Buy rating on Achieve Life Sciences (ACHV – Research Report) today and set a price target of ...

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...